|
|
||||||||
Ann Thorac Surg 1997;63:1085-1090
© 1997 The Society of Thoracic Surgeons
Division of Cardiothoracic Surgery, Department of Surgery, and Division of Cardiology, Department of Medicine, University of California, Los Angeles, School of Medicine, Los Angeles, California
Accepted for publication November 2, 1996.
| Abstract |
|---|
|
|
|---|
Methods. Between 1982 and 1994, 21 adults aged 18 to 40 years (mean age, 27 ± 7 years) underwent a Fontan procedure. Anatomic diagnosis was tricuspid atresia in 9, double-inlet left ventricle in 4, and various single ventricles in 8. Four underwent a right atria-right ventricle connection, 13 had a right atria-pulmonary artery connection, and 4 had a lateral-tunnel Fontan. Three of these 4 had a snare-adjustable atrial septal defect. Preoperative risk factors assessed were left ventricular end-diastolic pressure greater than 10 mm Hg, ejection fraction lower than 0.45, mean pulmonary artery pressure higher than 15 mm Hg, transpulmonary gradient greater than 10 mm Hg, pulmonary artery abnormalities, and atrioventricular valve regurgitation. Mean preoperative risk score was 1.6 ± 1.1. Mean New York Heart Association class was 2.6 ± 0.5.
Results. The operative mortality rate was 5% (1/21). Six patients (30%) had a major complication, four being prolonged effusions. One patient was lost to follow-up; the remaining 20 have been followed for a mean of 7.4 ± 3.8 years. At follow-up, mean New York Heart Association class was 1.7 ± 0.5. There has been one late death (5%) at 9
years, which was probably due to ventricular arrhythmia. Three patients (16%) have required and survived reoperation. During follow-up, 7 patients (37%) have had development of atrial arrhythmias requiring medication, and 2 have been treated for ventricular arrhythmias.
Conclusions. These results indicate that properly selected adults can undergo the Fontan procedure with low morbidity and mortality. However, late-developing arrhythmias, need for reoperation, and decreasing ventricular function are serious problems that mandate careful follow-up.
| Introduction |
|---|
|
|
|---|
| Material and Methods |
|---|
|
|
|---|
Anatomic diagnosis was tricuspid atresia in 9 patients, double-inlet left ventricle in 4, complex unbalanced double-outlet right ventricle in 3, and various complex single ventricles in 5. Ventricular morphology was left in 16, right in 3, and undetermined in 2. Eleven patients had undergone 15 previous systemic-pulmonary artery shunts (13 Blalock-Taussig and two Potts). Two patients had pulmonary artery bands, and 8 patients had had no prior palliation. Two patients who were initially palliated with a Blalock-Taussig shunt were converted to a classic Glenn shunt 24 years and 10 years before a Fontan procedure. Four patients underwent a right atria-right ventricle conduit procedure, 13 patients had a right atria-pulmonary artery connection, and 4 patients had a lateral-tunnel Fontan procedure. Three of these 4 had a snare-adjustable atrial septal defect, and 2 of the 4 had a "unidirectional" (superior vena cava-left pulmonary artery and inferior vena cava-right pulmonary artery) Fontan procedure. In the "unidirectional" Fontan operation, the higher-volume inferior vena cava flow is directed to the larger-volume right lung, and the lower-volume superior vena cava blood flow is directed to the smaller-volume left lung. This is anatomically the opposite of the classic Glenn shunt.
In a retrospective manner, an attempt was made to assess the operative risk of these patients. As risk assessment for the Fontan procedure has evolved substantially over the last decade, the selection factors were not specifically used at the time of each patient's surgical procedure to determine operability. Although the selected factors are somewhat arbitary, they could be reliably assessed for all patients over the 13-year span of this review. As such, the following risk factors were assessed: left ventricular end-diastolic pressure higher than 10 mm Hg, ejection fraction lower than 0.45, mean pulmonary artery pressure greater than 15 mm Hg, transpulmonary gradient greater than 10 mm Hg (defined as preoperative mean pulmonary artery pressure minus left atrial pressure), pulmonary artery abnormalities requiring operative repair, and atrioventricular valve regurgitation of a moderate degree or greater. One point was given for each preoperative risk factor identified, and the mean score was 1.6 ± 1.1 (range, 0 to 4).
Age range was 18 to 40 years (mean age, 27 ± 7 years), and there were 12 men and 9 women. Mean preoperative New York Heart Association (NYHA) class was 2.6 ± 0.5. Indications for operation were variable and included major or increasing cyanosis with marked polycythemia, increasing functional limitation, or concern about chronic volume overload with increasing ventricular size in patients with a previously placed shunt.
A summary of the patient data is shown in Table 1
.
|
| Results |
|---|
|
|
|---|
| Late Mortality |
|---|
|
|
|---|
years after operation. The patient had tricuspid atresia and had undergone a right atria-right ventricle conduit type of Fontan repair. One year postoperatively, she was noted to have atrioventricular node reentry tachycardia and was treated with amiodarone hydrochloride and an AAI pacemaker. Subsequently, amiodarone had to be withdrawn, and radiofrequency ablation of the atrioventricular node with placement of a DDD pacemaker was performed. She continued to have both atrial and ventricular arrhythmias and was being medically treated for them at the time of death. The actuarial survival rate at 3, 6, and 12 years was 95%, 95%, and 81%, respectively (Fig 1
|
| Morbidity |
|---|
|
|
|---|
| Reoperations |
|---|
|
|
|---|
|
| Arrhythmias |
|---|
|
|
|---|
years after operation, and the other has progressively deteriorating ventricular function and will likely undergo heart transplantation within 1 or 2 years. An additional 2 patients have had complete heart block remote from the Fontan procedure. In 1 of them it was therapeutically induced to treat reentrant atrioventricular node tachycardia, and in another it occurred spontaneously. Both patients had DDD pacemakers placed. | NYHA Class |
|---|
|
|
|---|
| Comment |
|---|
|
|
|---|
Nevertheless, occasional adult patients are encountered who are anatomic candidates for the Fontan procedure but have not undergone definitive palliation. Here we chronicle our experience with 21 such patients palliated with various modifications of the Fontan procedure. The mean NYHA class before operation was 2.6 ± 0.5, indicating that the patients were fairly symptomatic and limited at the time of operation. At mean follow-up of 7.4 ± 3.8 years, the NYHA class of survivors was 1.7 ± 0.5, suggesting that the majority of patients were enjoying substantial symptomatic improvement. Of the 6 patients followed up less than 5 years, 3 were in NYHA class I and 3, in class II. Of the 13 patients followed up 5 years or more, 3 were in NYHA class I and 10, in class II. This suggests that increasing disability is to be anticipated in this group as time from operation is extended and is similar to the findings of Fontan and co-workers [7] in a larger and more age-diverse group.
Early mortality in this series was 1 (5%) of 21 patients. This is similar to the experience of Mayer [5], Kirklin [6], Mair [13], Humes [14], Mair [15], and their associates, who reported a mortality rate of 8% for a group of 25 patients older than 15 years, 7% for a group of 14 patients older than 20 years, 6% for a group of 16 patients more than 18 years old, 6% for a group of 77 patients older than 17 years, and 10% for a group of 121 patients greater than 17 years old, respectively. However, it is difficult to directly compare these studies with our study, as specific and individual patient risk factor were not provided in the other studies.
To present our results in this age group with reference to some currently accepted risk factors for the Fontan operation, we developed a system for assessing risk that could be applied over the 13 years of the study. One point each was given for left ventricular end-diastolic pressure greater than 10 mm Hg, ejection fraction of less than 0.45, mean pulmonary artery pressure higher than 15 mm Hg, transpulmonary gradient greater than 10 mm Hg (as previously defined), pulmonary artery abnormalities requiring operative repair, and atrioventricular valve regurgitation of a moderate degree or greater. Mean score was 1.6 ± 1.1 with a range of 0 to 4 (see Table 1
). These data may serve as a benchmark for anticipated results for patients with similar profiles and imply that low operative mortality can be expected in this age range in a well-selected moderate-risk group. The only early death that occurred involved a 23-year-old woman with heterotaxia/asplenia syndrome, double-outlet right ventricle with unbalanced atrioventricular canal, malpositioned great vessels, and total anomalous pulmonary venous connections. She was at increased risk with a left ventricular end-diastolic pressure higher than 10 mm Hg, an ejection fraction lower than 0.45, and pulmonary artery pressures that were not directly measured. Although not assessed as a risk factor in this study, the asplenia/polysplenia syndromes also convey increased risk [16].
The actuarial survival rate in this series at 3, 6, and 12 years was 95%, 95%, and 81%, respectively. The one late death occurred 9
years postoperatively and was unwitnessed and sudden. However, this patient had a history of ventricular arrhythmia and declining ventricular function, and her death was quite likely cardiac related. With a mean follow-up of 7.4 ± 3.8 years and 6 patients followed longer than 10 years, this study suggests that the modified Fontan procedure does provide very good palliation and systematic improvement in this older age group over a 10-year period. Nonetheless, a significant incidence of late atrial arrhythmias and a decline in the functional status and ventricular function of some patients followed lead us to believe that the survival curve will continue to decline in the 10- to 20-year interval. Such a trend would be similar to the one in the report of Fontan and colleagues [7] on a heterogeneous group of 334 patients.
Morbidity in this series was related primarily to prolonged pleural drainage, which occurred in 4 patients (19% overall). This complication was seen only early in the series; none of the 3 recent patients treated with a lateral-tunnel, snare-adjustable atrial septal defect Fontan procedure and neither of the 2 having reoperation with a lateral-tunnel, snare-adjustable atrial septal defect Fontan sustained prolonged drainage. We believe this is a direct result of the lower right atrial pressure, which can be individually tailored with the snare-adjustable atrial septal defect [17]. At a time remote from operation, the snare-adjustable atrial septal defect can be completely closed with elevation of right atrial pressure but without the frequent occurrence of pleural effusion [18].
Three patients (16%) required reoperation, and the rate of actuarial freedom from reoperation was 94%, 87%, and 69% at 3, 6, and 12 years, respectively. The cause of two reoperations was related to technique-a late atrial baffle leak and rapid obstruction of a right atria-right ventricle Dacron conduit. The final reoperation was of most interest and was pursued electively. Eleven years previously, this patient had undergone a right atria-pulmonary artery type of Fontan procedure and had subsequently had development of a grossly dilated atrium, atrial dysrrhythmias, atrioventricular valve regurgitation, and elevated right atrial pressure. The patient was converted to a lateral-tunnel, snare-adjustable atrial septal defect Fontan with resection of excess atrial tissue and valve repair. This approach, which has been used in other patients with late atrial dilatation and arrhythmias [19], was helpful in controlling the atrial rhythm and improving the patient's functional status. Whether this approach will yield long-term improvement has yet to be determined, but early results are encouraging.
The most disturbing long-term follow-up problem encountered has been atrial arrhythmias. At varying intervals, 7 patients (37%) have had atrial arrhythmias requiring medical therapy. This incidence is similar to the 32% and 57% incidence reported by Peters and Somerville [20] and Cromme-Dijkhuis and colleagues [21], respectively, in their mid-term and long-term follow-up of Fontan patients. It is important to note, however, that this high incidence of atrial arrhythmias is essentially no different from that reported for adult patients with tricuspid atresia and normally related or transposed great arteries who have not undergone a Fontan type of procedure [22, 23]. Thus, there is no clear evidence that these arrhythmias are a direct consequence of Fontan palliation.
Nonetheless, it is clear that atrial enlargement, elevated pulmonary artery pressure, elevated right atrial pressure, and older age are risk factors for the development of late atrial arrhythmias [24]. Operative strategies, such as the lateral-tunnel Fontan or partial Fontan, that attempt to limit atrial enlargement and maintain low right atrial pressures should be aggressively pursued. This is particularly true in the older age group. More recent reports suggesting that atrial incisions themselves may be in part responsible for late atrial arrhythmias argue for the extracardiac conduit approach to the lateral-tunnel Fontan concept [25]. Such an approach may be ideally suited to the low-risk adult patient, as outgrowth of the conduit is not a concern. Nonetheless, in higher risk patients, if an extracardiac conduit is used, an approach that can incorporate an adjustable atrial septal defect is recommended.
Older patients in whom atrial arrhythmias develop should be screened for atrial enlargement, atrial thrombosis, ventricular function, and valvular regurgitation. Serious consideration should be given to valvular repair or atrial reduction with conversion to a lateral-tunnel Fontan procedure in patients with acceptable operative risk and decreased functional status related to the recent onset of atrial arrhythmia. Ventricular function should be carefully noted in this group of patients. Our experience has been that patients with ventricular enlargement, a significantly depressed ejection fraction, and atrial arrhythmias represent a high-risk group for reoperation and that cardiac transplantation should be considered.
| Footnotes |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
H. Laks, D. Marelli, M. Plunkett, and J. Myers Adult Congenital Heart Disease Card. Surg. Adult, January 1, 2008; 3(2008): 1431 - 1464. [Full Text] |
||||
![]() |
A. R. Mott, T. F. Feltes, E. D. McKenzie, D. B. Andropoulos, L. I. Bezold, A. L. Fenrich, S. L. Bedford, H. El-Said, S. A. Stayer, and C. D. Fraser Jr Improved early results with the Fontan operation in adults with functional single ventricle Ann. Thorac. Surg., April 1, 2004; 77(4): 1334 - 1340. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Burkhart, J. A. Dearani, D. D. Mair, C. A. Warnes, C. C. Rowland, H. V. Schaff, F. J. Puga, and G. K. Danielson The modified Fontan procedure: Early and late results in 132 adult patients J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1252 - 1259. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ovroutski, V. Alexi-Meskishvili, P. Ewert, J.-H. Nurnberg, R. Hetzer, and P.E. Lange Early and medium-term results after modified Fontan operation in adults Eur. J. Cardiothorac. Surg., March 1, 2003; 23(3): 311 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Laks, D. Marelli, M. Plunkett, J. Odim, and J. Myers Adult Congenital Heart Disease Card. Surg. Adult, January 1, 2003; 2(2003): 1329 - 1358. [Full Text] |
||||
![]() |
G R Veldtman, A Nishimoto, S Siu, M Freeman, P M Fredriksen, M A Gatzoulis, W G Williams, and G D Webb The Fontan procedure in adults Heart, September 1, 2001; 86(3): 330 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ghai, L. Harris, D. A. Harrison, G. D. Webb, and S. C. Siu Outcomes of late atrial tachyarrhythmias in adults after the Fontan operation J. Am. Coll. Cardiol., February 1, 2001; 37(2): 585 - 592. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |